Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome

Clinical Microbiology Reviews

Volumn 12, Issue 2, 1999, Pages 224-242

  Ladhani, Shamez ^a   Joannou, Christopher L ^a   Lochrie, Denise P ^a   Evans, Robert W ^a   Poston, Susan M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; EXFOLIATIN; SUPERANTIGEN;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; HUMAN; INFECTION PREVENTION; INFECTION SENSITIVITY; REVIEW; STAPHYLOCOCCUS AUREUS; TOXIC EPIDERMAL NECROLYSIS;

EID: 0032916431     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.12.2.224     Document Type: Review

References (291)

1. Abe, J., B. L. Kotzin, K. Jujo, M. E. Melish, M. P. Glode, T. Kohsaka, and D. Y. Leung. 1992. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2- and Vβ8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 89:4066-4070.
2. Acharya, K. R., E. F. Passalacqua, E. Y. Jones, K. Harlos, D. I. Stuart, R. D. Brehm, and H. S. Tranter. 1994. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367:94-97.
3. Ackerman, A. B. 1978. Histologic diagnosis of inflammatory skin disease, p. 169. Lea & Febiger, Philadelphia, Pa.
4. Adesiyun, A. A., W. Lenz, and K. P. Schaal. 1991. Exfoliative toxin-production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria. Microbiologica 14:357-362.
5. Adlam, C., J. C. Anderson, J. P. Arbuthnott, C. S. F. Easmon, and W. C. Noble. 1983. Staphylococci and staphylococcal infections, vol. 1, p. 357-384. Academic Press, Ltd., London, United Kingdom.
6. Allen, K. D., E. J. Ridgeway, and L. A. Parsons. 1994. Hexachlorophane powder and neonatal staphylococcal infection. J. Hosp Infect 27:29-33.
7. Almquist, E. 1891. Pemphigus neonatorum, backteriologisch und epidemiologisch beleuchtet. Z. Hyg. Infectionskr. 10:253
8. Aly, R., H. I. Maibach, and H. R. Shinefield. 1977. Microbial flora of atopic dermatitis. Arch. Dermatol. 113:780-782.
9. Amon, R. B., and R. L. Dimond. 1975. Toxic epidermal necrolysis: rapid differentiation between staphylococcal and drug-induced disease. Arch. Dermatol. 111:1433-1437.
10. Anderson, J. M., F. Cockburn, J. Q. Forfar, R. A. Harkness, R. W. Kelly, and B. Kilshaw. 1981. Neonatal spongiform myelinopathy after restricted application of hexochlorophane skin disinfectant. J. Clin. Pathol. 34:25-29.
11. Annunziato, D., and L. M. Goldblum. 1978. Staphylococcal scalded skin syndrome. Am. J Dis. Child 132:1187-1188.
12. Arbuthnott, J. P., C. G. Gemmell, J. Kent, and A. Lyell. 1969. Hemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis. Ritter's disease, and impetigo contagiosa J Med. Microbiol. 2:479-487.
13. Arbuthnott, J. P., J. Kent, A. Lyell, and C. G. Gemmell. 1971. Toxic epidermal necrolysis produced by an extracellular product of Staphylococcus aureus. Br. J. Dermatol. 85:145-149
14. Arbuthnott, J. P., J. Kent, and W. C. Noble. 1973 The response of hairless mice to staphylococcal epidermolytic toxin. Br. J. Dermatol. 88:481-485.
15. Arbuthnott, J. P., B. Billcliffe, and W. D. Thompson. 1974. Isoelectric focusing studies of staphylococcal epidermolytic toxin. FEBS Lett. 46:92-95.
16. Arbuthnott, J. P., and B. Billcliffe. 1976. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin. J. Med. Microbiol. 9:191-201
17. Arbuthnott, J. P. 1981 Characterisation of the epidermolytic toxins of Staphylococcus aureus, p 109-118 In A MacDonald and G. Smith (ed.), The staphylococci. Proceedings of the Alexander Ogsten Centennial Conference. Aberdeen University Press, Aberdeen, United Kingdom.
18. Avakian, R., F. P. Flowers, O. E. Araujo, and F. A. Ramos-Caro. 1991. Toxic epidermal necrolysis: a review J. Am. Acad. Dermatol. 31:301-302.
19. Ayliffe, G. A. J., K. M. Brightwell, B. J. Collins, E. J. L. Lowbury, P. C. L. Goonatilake, and R. A. Etheridge. 1977. Studies of hospital infection in Birmingham region. J. Hyg. Camb. 79:229-314.
20. Ayliffe, G. A. 1997. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24(Suppl. 1):S74-S79.
21. Bailey, C. J., J. DeAzavedo, and J. P. Arbuthnott. 1980 A comparative study of two serotypes of epidermolytic toxins from Staphylococcus aureus. Biochim. Biophys. Acta 624:111-120.
22. Bailey, C. J., and T. P. Smith. 1990 The reactive serine residue of epidermolytic toxin A. Biochem. J. 269:535-537.
23. Bailey, C. J., and M. B. Redpath. 1992. The esterolytic activity of epidermolytic toxins Biochem. J. 284:177-180.
24. Bailey, C. J., B. P. Lockhart, M. B. Redpath, and T. P. Smith. 1995. The epidermolytic (exfoliative) toxins of Staphylococcus aureus. Med. Microbiol. Immunol. 184:53-61
25. Barbosa, J. A. R. G., J. W. Saldanha, and R. C. Garratt. 1996. Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins. Protein Eng 9:591-601.
26. Barr, J. 1984. The umbilical cord: to treat or not to treat? Midwives Chron. Nursing Notes 97:224-226.
27. Beers, B., and B. Wilson. 1990. Adult staphylococcal scalded skin syndrome. Int. J. Dermatol. 29:428.
28. Beharka, A. A., J. W. Armstrong, J. J. Iandolo, and S. K. Chapes. 1994. Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins. Infect. Immun 62:3907-3915.
29. Bell, F. G., and P. A. Fenton. 1993. Early hospital discharge and cross-infection. Lancet 342:120.
30. Benson, P. F., G. L. S. Rankin, and J. Rippey. 1962 An outbreak of exfoliative dermatitis of the newborn (Ritter's disease) due to Staphylococcus aureus, phage type 55/71. Lancet i:999-1002
31. Blackwell, C. C., A. T. Saadi, M. W. Raza, D. M. Wier, and A. Busuttil. 1993. The potential role of bacterial toxins in sudden infant death syndrome. Int. J. Leg. Med. 105:333-338.
32. Blanc, M. F., and M. Janier. 1986. Staphylococcies exfoliantes (SSSS) de l'adulte. Ann Dermatol Vererol. 113:833-843.
33. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxin shock syndromes and related diseases. Crit Rev. Microbiol. 17:251-272.
34. Borchers, S. L., E. C. Gomez, and R. R. Isseroff. 1984 Generalised staphylococcal scalded skin syndrome in an anephric boy undergoing haemodialysis. Arch. Dermatol. 120:912-918.
35. Boyce, J. M. 1992. Methicillin-resistant Staphylococcus aureus in hospitals and long-term facilities: microbiology, epidemiology, and preventative measures. Infect. Control Hosp. Epidemiol. 13:725-737
36. Boyer, M. D. P., and K. J. Reis. 1987 Bacterial Fc receptors. Bio/Technology 5:697-703.
37. Brady, L., A. M. Brzozowski, Z. S. Derewenda, E. Dodson, G. Dodson, S. Tolley, J. P. Turkenburg, L. Christensen, B. H. Huge-Jensen, L. Norskov, L. Thim, and U. Menge. 1990. A serine protease triad forms the catalytic centre of a triacylglycerol lipase. Nature (London) 343:767-770.
38. Bremmell, T., and A. Tarkowski. 1995. Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci. Infect. Immun. 63:4185-4187.
39. Brocke, S., T. Veromaa, I. L. Weissman, K. Gijbels, and L. Steinman. 1994. Infection and multiple sclerosis: a possible role for superantigens? Trends Microbiol 2:250-254.
40. Brook, M. G., and B. A. Bannister. 1991. Staphylococcal enterotoxins in scarlet fever complicating chicken pox. Postgrad. Med. J. 67:1013-1014.
41. Brzozowski, A. M., U. Derewenda, Z. S. Derewenda, G. G. Dodson, D. M. Lawson, J. P. Turkenburg, F. Bjorking, B. Huge-Jensen, S. A. Patkar, and L. Thim. 1991. A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex. Nature 351:491-494.
42. Buslau, M., H. Biermann, and P. M. Shah. 1996 Gram-positive septic-shock with bullae Intraepidermal splitting as an indication of toxin effect. Hautarzt 47:783-789. (In German.)
43. Carpenter, R. G., and A. Gardener. 1967. Studies of medical and population subjects, publication 45, p. 23-31. Her Majesty's Stationary Office, London, United Kingdom
44. Cavarelli, J., G. Prevost, W. Bourguet, L. Moulinier, B. Chevrier, B. Delagoutte, A. Bilwes, L. Mourey, S. Rifai, Y. Piemont, and D. Moras. 1997. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7Å resolution. Structure 5:813-824.
45. Chapes, S., S. M. Hoynowski, K. M. Woods, J. W. Armstrong, A. A. Beharka, and J. J. Iandolo. 1994. Staphylococcus-mediated T-cell activation and spontaneous natural killer cell activity in the absence of major histocompatibility complex class II molecules. Infect. Immun. 61:4013-4016.
46. Choi, Y., B. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1990. Interaction of Staphylococcus aureus toxin superantigens with human T cells Proc Natl Acad. Sci. USA 86:8941-8945
47. Corner, B. D., S. T. Crowther, and S. M. Eades. 1960. Control of staphylococcal infection in a maternity hospital. Br. Med. J. 1:1927-1929.
48. Cribier, B., Y. Piemont, and E. Grosshans. 1984. Staphylococcal scalded skin syndrome in adults: a clinical review illustrated with a case J. Am. Acad. Dermatol 30:319-324.
49. Curran, J. P., and F. L. Al-Salihi. 1980. Neonatal staphylococcal scalded skin syndrome: massive outbreak due to an unusual phage type Pediatrics 66:285-290.
50. Dajani, A. S. 1972 The scalded skin syndrome: relation to phage group II staphylococci. J Infect. Dis. 125:548.
51. Dancer, S. J., N. A. Simmons, S. M. Poston, and W. C. Noble. 1988. Outbreak of staphylococcal scalded skin syndrome among neonates. J. Infect. 16:87-103.
52. Dancer, S. J., S. M. Poston, J. East, N. A. Simmons, and W. C. Noble. 1990. An outbreak of pemphigus neonatorum. J. Infect 20:73-82.
53. Dancer, S. J., R. Garratt, J. Saldanha, H. Jhoti, and R. Evans. 1990 The epidermolytic toxins are serine proteases. FEBS Lett. 268:129-132.
54. Dancer, S. J., and W. C. Noble. 1991. Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin. J. Clin. Pathol. 44:681-684.
55. Dave, J., S. Reith, J. Q. Nash, R. R. Marples, and C. Dulake. 1994. A double outbreak of exfoliative-toxin producing strains of Staphylococcus aureus in a maternity unit. Epidemiol. Infect 112:103-114.
56. De Azavedo, A., and J. P. Arbuthnott. 1981 Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus. J. Med Microbiol. 14: 341-344.
57. De Azavedo, A., and J. P. Arbuthnott. 1988. Assays for epidermolytic toxins of Staphylococcus aureus. Methods Enzymol 165:333-337.
58. Dedobbeleer, G., and G. Achten. 1975. Staphylococcal scalded skin syndrome. An ultrastructural study. J. Cutaneous Pathol. 2:91-96.
59. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
60. Dillon, H. C. 1968 Impetigo contagiosa: suppurative and non-suppurative complications. Am. J. Dis. Child. 115:530-541
61. Dillon, H. C. 1980. Topical and systemic therapy for pyodermas. J. Dermatol 19:443-451.
62. Dimond, R. L., H. H. Wolff, and O. Braun-Fulco. 1977. The staphylococcal scalded skin syndrome. An experimental histochemical and electron microscopic study. Br. J. Dermatol. 96:483-492
63. Donahus, D., B. Robinson, and N. S. Goldberg. 1991. Staphylococcal scalded skin syndrome in a woman with chronic renal failure exposed to human immunodeficiency virus. CUTIS 47:317
64. Drapeau, G. R. 1978. The primary structure of Staphylococcus aureus. Can J. Biochem. 56:534-544.
65. Easterley, N. B., and L. M. Solomon. 1970. Neonatal dermatology II: blistering and scaling dermatoses. J. Paediatr 77:1075-1088.
66. Elbaum, D. J., C. Wood, F. Abuabara, and V. B. Morhenn. 1984. Bullae in a patient with toxic shock syndrome. J. Am. Acad. Dermatol 10:267-272.
67. Elias, P. M., K. A. Arndt, and G. C. Peck. 1973. Scalded skin syndrome in adults. N. Engl. J Med. 288:582
68. Elias, P. M., P. Fritsch, M. V. Dahl, and K. Wolff. 1975. Staphylococcal toxic epidermal necrolysis: pathogenesis and studies on the subcellular site of action of exfoliatin J Investig Dermatol 65:501-512
69. Elias, P. M., P. Fritsch, and H. Mittermayer. 1976. Staphylococcal toxic epidermal necrolysis. species and tissue susceptibility and resistance. J. Investig. Dermatol 66:80
70. Elias, P. M., P. Fritsch, and E. H. Epstein Jr. 1977. Staphylococcal scalded skin syndrome. Arch. Dermatol. 113:207-219.
71. Elsner, P., and A. A. Hartman. 1988. Epidemiology of ETA- and ETB-producing staphylococci in dermatological patients Zentbl. Bacteriol. Mikrobiol Hyg. Ser. A 268:534.
72. Falk, D. K., and L. E. King. 1983. Criteria for the diagnosis of staphylococcal scalded skin syndrome in adults CUTIS 31:421-424.
73. Feder, H. M., D. M. Hoss, and R. L. Dimond. 1996. Toxic epidermal necrolysis N. Engl. J. Med. 334:922-923.
74. Feldman, C. A. 1962. Staphylococcal scarlet fever N Engl. J. Med. 267: 877-878.
75. Feldman, S. R. 1993. Bullous dermatoses associated with systemic disease. Dermatol. Clin. 11:597-609
76. Ferscht, A. R. 1985. Enzyme structure and mechanism, 2nd ed. W H. Freeman & Co., New York, N.Y
77. Fields, B. A., E. L. Malchiodi, H. Li, X. Ysern, C. V. Stauffacher, and P. M. Schlievert. 1996. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384:188-192.
78. Finch, R. 1988 Skin and soft-tissue infections. Lancet i:164-168.
79. Finch, R. G., and M. Whitby. 1985 Toxic-shock syndrome. J R. Coll. Physicians London 19:219.
80. Fleischer, B., and H. Schrezenmeier. 1988. T cell stimulation by staphylococcal enterotoxins: clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167:1697-1707.
81. Fleischer, B., H. Schrezenmeier, and P. Conradt. 1989. T lymphocyte activation by staphylococcal enterotoxins role of class II molecules and T cell surface structures. Cell Immunol. 120:92-101.
82. Fleischer, B., and C. J. Bailey. 1992. Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen. Med. Microbiol. Immunol. 180:273-278.
83. Fleischer, B., D. Gerlach, A. Fuhrmann, and K. H. Schmidt. 1995. Superantigens and pseudosuperantigens of gram-positive cocci. Med. Microbiol Immunol. 184:1-8.
84. Fleming, S. D., J. J. Iandolo, and S. K. Chapes. 1991. Murine macrophage activation by staphylococcal exotoxins. Infect. Immun. 59:4049-4055.
85. Fleurette, J., and J. Ritter. 1980. Prevalence des souches de Staphylococcus aureus productrices d'exfoliatine dans le groupe bacteriopagique II. Ann. Microbiol. 1131B(2):175-183
86. Fligner, C. L., R. Jack, G. A. Twiggs, and V. A. Raisys. 1985. Hyperosmolality induced by propylene glycol - a complication of silver sulfadiazine therapy. JAMA 253:1606.
87. Forfar, J. O., C. L. Bale, and T. F. Elias-Jones. 1953. Staphylococcal infection of the newborn. Br. Med. J. 2:170-174.
88. Forsgren, A. 1970. Significance of protein A production by staphylococci. Infect. Immun. 2:672-673.
89. Forsgren, A., L. Nordstrom, L. Phillipson, and B. Szoquist. 1971. Protein A mutants of Staphylococcus aureus. J Bacteriol 107:245-250.
90. Freedman, J. D., and D. J. Beers. 1991. Expanding perspectives on the toxic shock syndrome. Adv. Intern. Med. 36:363.
91. Freer, J., and J. P. Arbuthnott. 1983. Toxins of Staphylococcus aureus. Pharmacol. Ther. 19:55-106.
92. Freinkel, R. K., and T. N. Traczyk. 1981. A method for partial purification of lamellar granules from fetal rat epidermis. J. Investig. Dermatol. 77:478-482.
93. Fritsch, P. 1975. Staphylogene toxische epidermale Nekrolyse. Z. Haut-Geschlechtstkr. 50:5.
94. Fritsch, P., P. Elias, and J. Varga. 1976. The fate of staphylococcal exfoliatin in newborn and adult mice. Br. J. Dermatol. 95:275-284.
95. Furue, M., K. So, U. Ogasa, H. Sugiyama, N. Ohtake, S. Sakurai, and K. Tamaki. 1995. Outbreak of staphylococcal scalded skin syndrome evaluated by DNA fingerprinting. Lancet 345:1308
96. Gemmell, C. G. 1995. Staphylococcal scalded skin syndrome J Med Microbiol. 43:318-327.
97. Gentilhomme, E., M. Faure, Y. Piemont, P. Binder, and J. Thivolet. 1990. Action of staphylococcal exfoliative toxins on epidermal cell cultures and organotypic skin. J. Dermatol 17:526-532.
98. Gershkovich, A. A. 1996 Inducing conformational changes in thrombin by ligands as a way of regulating its activity. Biochemistry (Moscow) 61:817-824. (In Russian.)
99. Gershkovtch, A. A., D. I. Kara, and V. K. Kibirev. 1996 Synthesis and study of a novel inhibitor of thrombin containing no side chain at the P1 position of the polypeptide chain. Semin. Thromb. Hemostasis 22:343-345. (In Russian.)
100. Ginsburg, C. M. 1991 Staphylococcal toxin syndromes. Pediatr. Infect Dis. J. 10:319-321.
101. Goldberg, N. S., T. Ahmed, B. Robinson, H. Ascensao, and H. Horwitz. 1989. Staphylococcal scalded skin syndrome mimicking acute graft-versus-host disease in a bone marrow transplant recipient. Arch. Dermatol. 15: 385-389.
102. Grayson, S., A. W. Johnson-Winegar, B. U. Wintroub, R. R. Isserott, E. H. Epstein, and P. M. Elias. 1984. Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterisation. J. Investig Dermatol 85:289-299
103. Hardwick, N., C. M. Parry, and G. R. Sharpe. 1995 Staphylococcal scalded skin syndrome in an adult: influence of immune and renal factors. Br. J. Dermatol 132:468-471.
104. Hardyment, A. F. 1958 Control of infections of newborn infants Pediatr Clin. North Am. 5:287-300.
105. Hargiss, C., and E. Larson. 1978. The epidemiology of Staphylococcus aureus in a newborn nursery from 1970 through 1976. Pediatrics (Springfield) 61:348-353
106. Herman, A., G. Croteau, R. P. Sekaley, J. Kappler, and P. Marrack. 1990. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells J. Exp Med 172:709-717.
107. Hermann, T., R. S. Acolla, and H. R. MacDonald. 1989. Different staphylococcal enterotoxins bind preferentially to distinct MHC class II isotypes. Eur. J. Immunol. 19:2171-2174
108. Hoegger, P. H., and P. Elsner. 1988. Transmission of exfoliatin-producing Staphyhcoccus aureus by an asymptomatic carrier. Pediatr Infect. Dis. J 7:344.
109. Hoffmann, M. L., L. M. Jablanski, K. K. Crum, S. P. Hackett, Y. L. Chi, C. V. Stauffacher, D. L. Stevens, and G. A. Bohach. 1994. Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect. Immun. 62:3396-3407.
110. Hoffmann, R., M. Lohner, N. Bohm, H. E. Schaefer, and J. Letitis. 1994. Staphylococcal scalded skin syndrome and consecutive septicaemia in a preterm infant. Pathol Res. Pract. 190:77-81.
111. Hurwitz, R. M., and A. B. Ackerman. 1985. Cutaneous pathology of the toxic shock syndrome Am. J. Dermatopathol. 7:563
112. Iandolo, J. J. 1989, Genetic analysis of extracellular toxins of Staphylococcus aureus. Annu. Rev Microbiol. 43:375-402.
113. Inaoki, M. 1990. Experimental studies on the mechanism of action of staphylococcal epidermolytic toxin A utilizing recombinant toxin. Nippon Hifuka Gakkai Zasshi 100:1405-1414. (In Japanese.)
114. Itani, O., R. Crump, F. Minoumi, and W. W. Tunnessen. 1992. Picture of the month: staphylococcal scalded skin syndrome. Am. J. Dis. Child. 146: 424-425
115. Jackow, C. M., J. C. Cather, V. Hearne, A. T. Asano, J. M. Musser, and M. Duvic. 1997. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood 89:32-40.
116. Jackson, M. P., and J. J. Iandolo. 1986. Cloning and expression of exfoliative toxin B gene from Staphylococcus aureus. J. Bacteriol. 166:574-580.
117. Jakeman, K. J., D. I. Rushton, H. Smith, and C. Sweet. 1991. Exacerbation of bacterial toxicity to infant ferrets by influenza virus possible role in sudden infant death syndrome. J Infect. Dis. 163:35-40.
118. Jaulhae, B., Y. Piemont, and G. Prevost. 1994. Staphylococcal exfoliative toxins induce proteolytic activity when combined with epidermis, p 280-282. In R Mollby, J. I. Flock, C. E Nord, and B Christensson (ed.), Staphylococci and staphylococcal infections Proceedings of the 7th International Symposium. Gustav Fischer Verlag, Stuttgart, Germany.
119. Jernigan, J. A., M. G. Titus, D. H. Groschel, S. Getchell-White, and B. M. Farr. 1996. Effectiveness of contact isolation during a hospital outbreak of methicilhn-resistant Staphylococcus aureus. Am. J. Epidemiol. 143:496-504.
120. Johnson, W. M., S. D. Tyler, E. P. Ewan, F. E. Ashton, D. R. Pollard, and K. R. Rosee. 1991. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin-1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol. 29:426-430.
121. Jones, L. D. 1961. Observation of exudative epidermitis. Vet. Med. 56:95-103
122. Kallman, J., E. Kihlstrom, L. Sjoberg, and J. Schollin. 1997. Increase in staphylococci in neonatal septicaemia: a fourteen-year study. Acta Paediatr. 86:533-538.
123. Kaplan, M. H., H. Chmel, H. Hseih, A. Staphens, and V. Brinsko. 1986. Importance of exfoliative toxin A producing Staphylococcus aureus strains isolated from clustered epidemics of neonatal pustulosis. J. Clin. Microbiol 23:83-91.
124. Kappler, J., B. Kotzin, L. Herron, E. W. Gelfand, R. D. Bigler, A. Boylston, S. Carrel, D. N. Posnett, and Y. Choi. 1989 V beta-specific stimulation of human T cells by staphylococcal toxins. Science 244:811-813.
125. Kapral, F. A., and M. M. Miller. 1971. Product of Staphylococcus aureus responsible for the scalded skin syndrome. Infect. Immun. 4:541-545.
126. Kapral, F. A., and M. M. Miller. 1972. Skin lesions produced by Staphylococcus aureus exfoliatin in hairless mice. Infect. Immun. 6:877-879.
127. Kapral, F. A. 1974. Staphylococcus aureus: some host-parasite interactions. Ann. N. Y. Acad. Sci. USA 236:267-275.
128. Kapral, F. A. 1975. Staphylococcus exfoliatin. p. 263-266. In D Schlessinger (ed.), Microbiology - 1975. American Society for Microbiology, Washington, D.C.
129. Khuong, M. A., O. Chosidow, N. El-Solh, J. Wechsler, Y. Piemont, J. C. Roujeau, and J. Revuz. 1993. Staphylococcal scalded skin syndrome in an adult: possible influence of non-steroidal anti-inflammatory drugs. Dermatologica 186:153-154.
130. Kim, J. L., K. A. Morgenstern, C. Lin, T. Fox, M. D. Dwyer, J. A. Landro, S. P. Chambers, W. Markland, C. A. Lepre, E. T. O'Malley, S. L. Harbeson, C. M. Rice, M. A. Murcko, P. R. Caron, and J. A. Thomson. 1996. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87:343-355.
131. Kondo, I., S. Sakurai, and Y. Sarai. 1975. Purification of exfoliatin produced by Staphylococcus aureus of bacteriophage group 2 and its physicochemical properties. Infect. Immun. 8:156-164.
132. Kondo, I., S. Sakurai, and Y. Sarai. 1974. New type of exfoliatin obtained from staphylococcal strains belonging to phage groups other than group II, isolated from patients with impetigo and Ritter's disease. Infect. Immun. 10:851-861.
133. Kondo, I., S. Sakurai, Y. Sarai, and S. Fukati. 1975. Two serotypes of exfoliatin and their distribution in staphylococcal strains isolated from patients with scalded skin syndrome. J. Clin. Microbiol. 1:397-400.
134. Kondo, I. 1976. Staphylococcal-exfoliatin A and B, p. 82-95. In I. Kato (ed.), Saikin dokuso kenkyu. Kyouritsu Press, Tokyo, Japan
135. Korting, H. C. 1994. Critical commentary to staphylococcal scalded skin syndrome and consecutive septicaemia in a preterm infant. Pathol. Res. Pract. 190:82-83.
136. Kotb, M., G. Majumdar, M. Tomal, and E. H. Beachey. 1990. Accessory cell-independent stimulation of human T cells by streptococcal M protein superantigen. J. Immunol. 145:1332-1336.
137. Kotb, M. 1995. Bacterial pyrogenic exotoxins as superantigens. Clin. Microbiol. Rev. 8:411-426.
138. Koyama, A., M. Kobayashi, N. Yamaguchi, K. Yamagata, K. Takano, M. Nakajima, F. Irie, M. Goto, M. Iragashi, and I. Litsuka. 1995. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 47:207-216.
139. Ladhani, S., C. Joannou, J. Cameron, S. Poston, R. Garrett, S. Robbie, and R. W. Evans. 1998. The epidermolytic toxins in the staphylococcal scalded skin syndrome, p. 81-82. In Proceedings of the Eighth European Conference on Bacterial Protein Toxins. Gustav Fischer Verlag, Stuttgart, Germany.
140. Ladhani, S., and R. W. Evans. 1998. Staphylococcal scalded skin syndrome, Arch. Dis. Child. 78:85-88.
141. Lautenschlager, S., C. Herzog, and W. Zimmerli. 1993 Course and outcome of bacteraemia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin. Infect. Dis. 16:567-573.
142. Lawrence, C. R. 1982. Effect of two different methods of umbilical cord care on its separation time. Midwives Chron. Nursing Notes 95:204-205.
143. Lawrence, J., A. S. Hodtsev, and D. N. Posnett. 1992. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vβ expression. Nature 358:255-259.
144. L'Ecuyer, C., and K. Jercho. 1966. Exudative epidermitis in pigs: etiological studies and pathology. Can. J. Comp. Med. Vet. Sci. 30:94-101.
145. Lee, C. Y., J. J. Schmidt, A. D. Johnson-Winger, L. Spero, and J. J. Iandolo. 1987. Sequence determination and comparison of exfoliative toxin A and toxin B genes from Staphylococcus aureus. J. Bacteriol. 169:3904-3909
146. Lee, S., A. J. Barson, D. B. Drucker, J. A. Morris, and D. R. Telford. 1987 Lethal challenges of gnotobiotic weanling rats with bacterial isolates from cases of sudden infant death syndrome (SIDS). J. Clin. Pathol. 40:1393-1396.
147. Leung, D. Y., R. Harbeck, P. Bina, R. F. Reiser, E. Yang, D. F. Norris, J. M. Hanifin, and H. A. Scampson. 1993. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens J. Clin. Investig. 92:1374-1380.
148. Leung, D. Y., C. Meissner, D. Fulton, and P. M. Schlievert. 1995. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J. Clin. Immunol. 15(Suppl. 6):11S-17S.
149. Leung, D. Y., M. Gately, A. Trumble, B. Ferguson-Darnell, P. M. Schlievert, and L. J. Picker. 1995. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp. Med. 181:747-753
150. Lever, R., K. Hadley, D. Downey, and R. Mackie. 1988. Staphylococcal colonisation in atopic dermatitis and the effect of topical mupirocin therapy. Br. J. Dermatol. 119:189-198.
151. Lewis, H. M., B. S. Baker, S. Bokth, A. V. Powles, J. J. Garioch, H. Valdimarsson, and L. Fry. 1993. Restricted T-cell receptor Vβ gene usage in the skin of patients with guttate and chronic plaque. psoriasis. Br. J. Dermatol. 129:514-520.
152. Leyden, J. J., H. I. Marples, and A. M. Kligman. 1974. Staphylococcus aureus in the lesions of atopic dermatitis Br. J. Dermatol. 90:525-530.
153. Lillibridge, C. D., M. E. Melish, and L. A. Glasgow. 1972. Site of action of exfoliative toxin in the staphylococcal scalded skin syndrome Pediatrics 50:728-738.
154. Lina, G., Y. Gillet, F. Vandenesch, M. E. Jones, D. Floret, and J. Etienne. 1997. Toxin involvement in staphylococcal scalded skin syndrome. Clin. Infect Dis. 25:1369-1373
155. Lingnau, W., and F. Allerberger. 1994. Control of an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) by hygienic measures in a general intensive care unit. Infect. 22(Suppl 2):S135-S139.
156. Lockhart, B. P., and C. J. Bailey. 1993. ELISA estimation of the binding of the epidermal toxin to neonatal mouse skin. Toxicon 31:569-576.
157. Longhead, J. L. 1992. Congenital staphylococcal scalded skin syndrome. report of a case. Pediatr. Infect Dis. J. 10:319-321.
158. Lowney, E. D., J. V. Baublis, G. M. Kreye, E. R. Harrell, and A. R. McKenzie. 1967. The scalded skin syndrome in small children. Arch. Dermatol. 95:359-369.
159. Lyell, A. 1956. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br. J. Dermatol. 68:355-361.
160. Lyell, A. 1967 A review of toxic epidermal necrolysis in Britain. Br. J. Dermatol 79:662-671
161. Lyell, A., H. M. Dick, and J. O. Alexander. 1969. Outbreak of toxic epidermal necrolysis associated with staphylococci. Lancet i:787-789.
162. Lyell, A. 1979. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br. J. Dermatol 100:69-86.
163. Machida, K. 1995 Immunological investigations on pathogenesis of staphylococcal scalded skin syndrome. J. Clin. Pathol. 43:547-556. (In Japanese.)
164. Marples, R. R., C. L. Heaton, and A. M. Kligman. 1973. Staphylococcus aureus in psoriasis. Arch. Dermatol. 107:568-570.
165. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
166. McCallum, H. M. 1972. Action of staphylococcal epidermolytic toxin on mouse skin in organ culture. Br. J. Dermatol. 86(Suppl. 8):40-41.
167. McFadden, J. P., W. C. Noble, and R. D. R. Camp. 1993. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin Br. J. Dermatol 128:631-632.
168. Meeberg, A., and R. Schoyen. 1985. Bacterial colonisation and neonatal infections. Acta Paediatr. Scand. 74:366-371.
169. Mehtar, S. 1994. The continuing problem of "Hospital Staphylococci": why? J. Chemother. 6(Suppl 4):25-40.
170. Melish, M. E., and L. A. Glasgow. 1970. The staphylococcal scalded skin syndrome: development of an experimental model. N. Engl J. Med. 282: 1114-1119.
171. Melish, M. E., L. A. Glasgow, and M. D. Turner. 1972. The staphylococcal scalded skin syndrome: isolation and partial characterisation of the exfoliative toxin. Br J. Dermatol. 125:129-140.
172. Melish, M. E., L. A. Glasgow, M. D. Turner, and C. B. Lillibridge. 1974. The staphylococcal epidermolytic toxin. its isolation, characterization and site of action. Ann. N. Y. Acad. Sci. 236:317-342.
173. Melish, M. E., F. S. Chen, S. Sprouse, M. Stuckey, and M. S. Murata. 1981 Epidermolytic toxin Staphylococcal infection: toxin levels and host response, p. 287-298. In J. Jeljaszewicz (ed.), Staphylococci and staphylococcal infections. Gustav Fischer Verlag, Stuttgart, Germany.
174. Melish, M. E. 1982. Staphylococci, streptococci and the skin: review of impetigo and staphylococcal scalded skin syndrome. Semin. Dermatol 1:101-109.
175. Melish, M. E. 1992. Kawasaki syndrome: a 1992 update. Pediatr. Dermatol. 9:335-337.
176. Millan, S. J., J. N. Baldwin, M. S. Rhein, and H. H. Weiser. 1960 Studies on the incidence of coagulase positive staphylococci in a normal unconfined population. Am. J. Public Health 50:791-798.
177. Mirabile, R., M. Wiser, L. R. Barot, and A. S. Brown. 1986. Staphylococcal scalded skin syndrome. Plast. Reconstr. Surg. 77:752-756.
178. Miwa, K., M. Fukuyama, T. Kunitomo, and H. Igarashi. 1994. Rapid assay for detection of toxic shock syndrome toxin-1 from human sera. J. Clin. Microbiol. 32:539-542.
179. Miyake, Y., T. Iwai, M. Sugai, K. Miura, H. Suginaka, and N. Nagasaka. 1991 Incidence and characterisation of Staphylococcus aureus from the tongues of children J. Dent. Res. 70:1045-1047.
180. Moras, D., J.-C. Thierry, J. Cavarelli, and Y. Piemont. 1984. Preliminary crystallographic data for exfoliative toxin B from Staphylococcus aureus. J. Mol. Biol. 175:89-91.
181. Morlock, B. A., L. Spero, and A. D. Johnson. 1980. Mitogenic activity of staphylococcal exfoliative toxin. Infect. Immun. 30:381-384.
182. Morris, J. A., D. Haran, and A. Smith. 1987. Hypothesis: common bacterial toxins are a possible cause of sudden infant death syndrome. Med. Hypotheses 22:211-222
183. Mortimer, E. A., E. Wolinsky, and C. H. Rammelkamp. 1965. The transmission of staphylococci by the hands of personnel, p. 46-61. In H. I. Maibach and G. Hildick-Smith (ed.), Skin bacteria and their role in infection. McGraw-Hill Book Co., New York, N.Y.
184. Mourad, W., R. Al-Daccak, T. Chatila, and R. S. Geha. 1993. Staphylococcal superantigens as inducers of signal transduction in MHC class-II-positive cells. Semin. Immunol. 5:47-55.
185. Mulligan, M. E., K. A. Murray-Leisure, B. S. Ribner, H. C. Standiford, H. F. John, J. A. Korvick, C. A. Kauffman, and V. L. Yu. 1993. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and treatment. Am. J. Med. 94:313-328.
186. Murono, K., K. Fujita, and H. Yoshioka. 1988. Microbiological characteristics of exfoliative toxin-producing Staphylococcus aureus. Pediatr. Infect. Dis. J. 7:313-315.
187. Murono, K., K. Fujita, and H. Yoshioka. 1988. Detection of staphylococcal exfoliative toxin by slide latex hemagglutination. J Clin. Microbiol. 26:271-274.
188. Murray, D. L., C. A. Earhart, D. T. Mitchell, D. H. Ohlandorf, R. P. Novick, and P. M. Schlievert. 1996. Localization of biologically important regions on toxic-shock syndrome toxin 1. Infect. Immun. 64:371-374.
189. Newbould, M. J., J. Malam, J. M. McIllmurray, J. A. Morris, D. R. Telford, and A. J. Barson. 1989. Immunohistological localisation of staphylococcal toxic shock syndrome toxin (TSST-1) antigen in sudden infant death syndrome. J. Clin. Pathol. 42:935-939.
190. Nilsson, E., C. Henning, and M. Hjorleifsson. 1986. Density of the microflora in hand eczema before and after topical treatment with a potent corticosteroid. J. Am. Acad. Dermatol. 15:192-197.
191. Noble, W. C. 1981 The micrococci, p. 152-181. Lloyd-Luke, London, United Kingdom.
192. Notermans, S., P. Timmermans, and J. Nagel. 1982. Interaction of staphylococcal protein A in enzyme-linked immunosorbent assays for detecting staphylococcal antigens. J. Immunol Methods 55:35-41.
193. Ochsendorf, F. R., H. Schofer, and R. Milbradt. 1988. Diagnostik des Lyell syndroms: SSSS oder TEN? Dtsch. Med. Wochenschr. 133:860-863.
194. Opal, S. M., A. D. Johnson-Winegar, and A. S. Cross. 1988. Staphylococcal scalded skin syndrome m two immunocompetent adults caused by exfoliatin B-producing Staphylococcus aureus. J. Clin. Microbiol. 26:1283-1286.
195. Oranje, A. P., W. Soekanto, A. Sukardi, V. D. Vuzévski, A. van der Willigen, and H. M. Afiani. 1991 Diffuse cutaneous mastocytosis mimicking staphylococcal scalded skin syndrome: report of three cases. Pediatr. Dermatol. 8:147-151.
196. O'Toole, P., and T. J. Foster. 1987. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus. J Bacteriol. 169:3910-3915.
197. Paliard, X., S. G. West, J. A. Lafferty, J. R. Clements, J. W. Kappler,
198. Papageorgiou, A. C., K. R. Acharya, R. Shapiro, E. F. Passalacqua, R. D. Brehm, and H. S. Tranter. 1995. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3:769-779.
199. Parker, M. T., A. J. H. Tomlinson, and R. E. O. Williams. 1955. Impetigo contagiosa: the association of certain types of Staphylococcus aureus and of Streptococcus pyogenes with superficial skin infections. J. Hyg. Camb. 53: 458-473.
200. Parker, M. T., and R. E. O. Williams. 1961. Further observations on the bacteriology of impetigo and pemphigus neonatorum. Acta Paediatr. Scand. 50:101-112.
201. Persson, B., G. Bengtsson-Olivecrona, S. Enerback, and T. Olivecrona. 1989. Structural features of lipoprotein lipase: lipase family relationships, binding interactions, non-equivalence of lipase co-factors, vitellogenin similarities and functional subdivision of lipoprotein lipase. Eur. J. Biochem. 179:39-45.
202. Pickard, S., G. Shankar, and K. Burnham. 1994. Langerhan cell depletion by staphylococcal superantigens. Immunology 83:568-572.
203. Piemont, Y., and H. Monteil. 1983. Mise en evidence par electrosynerese des deux serotypes d'exfoliatine produits par Staphylococcus aureus. Ann. Microbiol. (Inst. Pasteur) 134A:169-175.
204. Piemont, Y., and H. Monteil. 1985. Rapid detection and quantitation of exfoliative toxin in staphylococcal cultures by electrosyneresis and enzyme-linked immunosorbent assay, p. 271-272 In J. Jeljaszewicz (ed.). The staphylococci, Gustav Fischer Verlag, Stuttgart, Germany.
205. Piemont, Y., S. Rifai, and H. Monteil. 1988. Les exfoliatines de Staphylococcus aureus. Bull. Inst. Pasteur 86:263-296.
206. Pittet, D., and R. P. Wenzel. 1995. Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths Arch. Intern. Med. 155:1177-1184.
207. Flaut, M. E., and M. Mirani. 1972. Toxic epidermal necrolysis due to E. coli. JAMA 219:1631-1632.
208. Pollack, S. 1996 Staphylococcal scalded skin syndrome Pediatr. Rev 17:18.
209. Prasad, G. S., C. A. Earhart, D. L. Murray, R. P. Novick, P. M. Schlievert, and D. H. Ohlendorf. 1993. Structure of toxic-shock syndrome toxin-1. Biochemistry 32:13761-13766.
210. Prevost, G., S. Rifai, L. Chaix, and Y. Piemont. 1991. Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin is essential for biological activity. Infect Immun. 59:3337-3339
211. Rasmussen, J. E. 1975. Toxic epidermal necrolysis: a review of 75 cases in children. Arch. Dermatol. 111:658-659.
212. Rasmussen, J. E. 1995. Erythema multiforme: should anyone care about standards of care? Arch Dermatol. 131:726-729.
213. Raymond, J., E. Bingen, N. Brahimi, M. Bergeret, J. Lepercq, J. Badoual, and D. Gendrel. 1997. Staphylococcal scalded skin syndrome in a neonate. Eur. J. Clin. Microbiol Infect. Dis. 16:453-454.
214. Redpath, M. B., T. J. Foster, and C. J. Bailey. 1991. The role of serine protease active site in the mode of action of epidermolytic toxin of S aureus. FEMS Microbiol. Lett. 81:151-156.
215. Revuz, J., D. Penso, J. C. Roujeau, J. C. Guillaume, C. R. Payne, J. Wechsler, and R. Touraine. 1987 Toxic epidermal necrolysis: clinical findings and prognostic factors in 87 patients. Arch. Dermatol. 123:1166-1170.
216. Rifai, S., V. Barbancon, G. Prevost, and Y. Piemont. 1989. Synthetic exfoliative toxin A and B DNA probes for detection of toxigenic Staphylococcus aureus strains. J. Clin. Microbiol. 27:504-506.
217. Rogers, S. E., and P. H. McKee. 1977. Toxic epidermal necrolysis in two patients with pustular psoriasis Br. J. Dermatol. 96:323
218. Rogolsky, M., B. B. Wiley, M. Keyhani, and L. A. Glasgow. 1974. Interaction of staphylococcal exfoliative toxin with concanavalin A. Infect. Immun. 10:1260-1265.
219. Rosten, P. M., K. H. Bartlett, and A. W. Chow. 1987 Detection of toxic shock syndrome toxin-1 in vivo and in vitro by noncompetitive enzyme-linked immunosorbent assay. J. Clin Microbiol. 25:327-332.
220. Rudolph, R. I., W. Schwartz, and J. J. Leyden. 1974. Treatment of staphylococcal toxic epidermal necrolysis Arch. Dermatol. 111:1135-1139.
221. Rycheck, R. R., P. M. Taylor, and H. M. Gezon. 1963. Epidemic staphylococcal pyoderma associated with Ritter's disease and the appearance of phage type 3b/71. N. Engl. J. Med. 269:332-337.
222. Saadi, A. T., C. C. Blackwell, M. W. Raza, V. S. James, J. Stewart, R. A. Elton, and D. M. Weir. 1993. Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome. Epidemiol. Infect. 110:507-517
223. Sakurai, S., and I. Kondo. 1979 A possible receptor substance for staphylococcal exfoliatin isolated from mice. Jpn. J. Med. Sci. Biol. 32:85-88.
224. Sakurai, S., H. Suzuki, and I. Kondo. 1987. Cloning of the gene coding for staphylococcal exfoliative toxin A and its expression in Escherichia coli. FEMS Microbiol. Lett. 42:63-67.
225. Sakurai, S., H. Suzuki, Y. Youhizawa, S. Mochizuki, and I. Kondo. 1994. Studies on toxicity and immunogenicity of staphylococcal exfoliative toxin, p. 283-285 In R. Mollby, J. I. Flock, C. E. Nord, and B. Christensson (ed.), Staphylococci and staphylococcal infections Proceedings of the 7th International Symposium. Gustav Fischer Verlag, Stuttgart, Germany.
226. Sakurai, S., H. Suzuki, and K. Machida. 1995. Rapid identification by polymerase chain reaction of staphylococcal exfoliative toxin serotype A and B genes. Microbiol. Immunol 39:379-386.
227. Salariya, E. M., and N. M. Kowbus. 1988. Variable umbilical cord care. Midwifery 4:70-76.
228. Saloga, J., A. H. Enk, D. Becker, M. Mohammadzadeh, S. Spieles, I. Bellinghausen, D. Y. Leung, E. W. Gelfand, and J. Knop. 1995. Modulation of contact sensitivity responses by bacterial superantigen. J. Investig. Dermatol. 105:220-224.
229. Samuels, M. J. 1967. Toxic epidermal necrolysis: a report of 42 cases. Br. J Dermatol. 79:672-677.
230. Sarai, Y., H. Nakahara, T. Ishikawa, I. Kondo, and S. Futaki. 1977. A bacteriological study on children with staphylococcal toxic epidermal necrolysis in Japan. Dermatologica 154:161-167.
231. Sarsfield, J. K. 1974. Battering: dangers of a backlash. Br. Med. J. 2:57.
232. Sato, H., T. Tanabe, M. Kuramoto, K. Tanaka, T. Hashimoto, and H. Saito. 1991. Isolation of exfoliative toxin from Staphylococcus hyicus subsp. hyicus and its exfoliative activity in the piglet. Vet. Microbiol. 27:263-275.
233. Sato, H., Y. Matsumori, T. Tanabe, H. Saito, A. Shimizu, A. Akira, and J. Kawano. 1994. A new type of staphylococcal exfoliative toxin isolated from a Staphylococcus aureus strain isolated from a horse with phlegmon. Infect. Immun. 62:3780-3785.
234. Schad, E. M., I. Zaitseva, V. N. Zaitsev, M. Dohlsten, T. Kalland, P. M. Schlievert, D. H. Ohlendorf, and L. A. Svensson. 1995. Crystal structure of the superantigen staphylococcal enterotoxin type A EMBO J 14:3292-3301
235. Schrezenmeier, H., and B. Fleischer. 1987 Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J. Immunol. Methods 105:133-137.
236. Schwartz, R. A. 1997. Toxic epidermal necrolysis. CUTIS 59:123-128.
237. Scopes, J. W., S. Eykyn, and I. Phillips. 1974. Staphylococcal infection in the newborn. Lancet 2:1392.
238. 2 fragments. J Clin. Microbiol. 27: 2050-2053
239. Seeberg, S., and B. Brinkoff. 1984. Epidemiology and control of staphylococcal pyoderma among newborn infants: evaluation of a method for routine care with a 4 percent chlorhexidine detergent solution. J. Hosp. Infect. 5:121-136.
240. Seeberg, S., B. Brinkoff, E. John, and I. Kjellmer. 1984. Prevention and control of neonatal proderma with chlorhexidine Acta Paediatr. Scand. 73:498-504.
241. Shaffer, T. E., J. N. Baldwin, and W. E. Wheeler. 1958. Staphylococcal infection in nurseries, p 243-281. In S. Z. Levine (ed.), Advances in pediatrics, vol 10 Year Book, Chicago, Ill.
242. Shands, K. N., G. P. Schmid, B. B. Dan, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: its association with tampon use and Staphylococcus aureus and the clinical features in 52 cases N. Engl. J. Med 303:1436
243. Sheridan, R. L., S. E. Briggs, J. P. Remensnyder, S. W. Gagnon, D. P. Doody, D. P. Ryan, and R. G. Tompkins. 1995. The burns unit as a resource for the management of acute non-burn conditions in children J. Burn Care Rehabil 16:62-64.
244. Simpson, K., and R. C. Tozer. 1960. Prevention of Staphylococcal sepsis in a maternity hospital by means of hexochlorophane. Br. Med. J. 1:315-317
245. Skov, L., and O. Baadsgaard. 1995, Superantigens: do they have a role in skin diseases? Arch. Dermatol. 131:829-832.
246. Smales, O. 1988. A comparison of umbilical cord treatment in the control of superficial infection. N Z. Med. J. 101:453-455
247. Smith, T. P., and C. J. Bailey. 1986. Epidermolytic toxin from Staphylococcus aureus binds to filaggrins. FEbS Lett. 194:309-312.
248. 247a. Smith, T. P., D. A. John, and C. J. Bailey. 1987 The binding of epidermolytic toxin from Staphylococcus aureus to mouse epidermal tissue. Histochem. J. 19:137-149.
249. Smith, T. P., D. A. John, and C. J. Bailey. 1989. Epidermolytic toxin binds to components in the epidermis of a resistant species. Eur. J. Cell Biol. 49:341-349
250. Smith, T. P., and C. J. Bailey. 1990 Activity requirements of epidermolytic toxins from Staphylococcus aureus studied by an in vitro assay. Toxicon 28:675-683
251. Starikov, A. V. 1995. Experience in using extracorporeal detoxication in the intensive therapy of autoimmune pathology. Likars'ka Sprava 9-12:155-157. (In Russian.)
252. Stark, V., and S. P. Harrison. 1992. Staphylococcus aureus colonization of the newborn in a Darlington Hospital. J Hosp. Infect. 21:205-211.
253. Stephen, J., and R. A. Pietrowski. 1986. Bacterial toxins, p. 8-10. American Society for Microbiology, Washington, D.C.
254. Stevens, F. A. 1927. Occurrence of Staphylococcus aureus infection with scarlantiniform rash. JAMA 88:1957-1958.
255. Stevens, D. L., M. H. Tanner, J. Winship, C. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
256. Stewart, G. A., R. Varro, and D. R. Stanworth. 1978. The influence of enzymatic cleavage and chemical modification of human and rabbit IgG on their reactivity with staphylococcal protein A. Immunology 35:785-791.
257. Stinnisen, P., C. Vandevyver, J. Raus, and J. Zhang. 1995. Superantigen reactivity of gamma delta cell clones isolated from patients with multiple sclerosis and controls. Cell. Immunol. 166:227-235.
258. Strange, P., L. Skov, and O. Baadsgaard. 1994. Interferon gamma-treated keratinocytes activate T cells in the presence of superantigens: involvement of major histocompatibility complex class II molecules. J. Investig. Dermatol. 102:150-154.
259. Streilein, J. W. 1989. Skin associated lymphoid tissue, p. 73-94. In D. A. Norris (ed.), Immune mechanisms in cutaneous disease. Marcel Dekker Inc , New York, N Y.
260. Su, Y. C., and A. C. L. Wong. 1995. Identification and purification of a new staphylococcal enterotoxin, H. Appl Environ. Microbiol. 61:1438-1443.
261. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992 Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801-806.
262. Tait, S. C. 1973. The hydrolysis of lipids and esters by Staphylococcus aureus. D.Phil. thesis. Paisley College of Technology, Paisley, United Kingdom
263. Takiuchi, I., I. Kawamura, T. Teramoto, and D. Higuchi. 1987. Staphylococcal exfoliative toxin induces caseinolytic activity. J. Infect. Dis. 156:508-509.
264. Tanabe, T., H. Sato, M. Kuramoto, and H. Saito. 1993. Purification of exfoliative toxin produced by Staphylococcus hyicus and its antigenicity. Infect. Immun. 61:2973-2977.
265. Tanabe, T., H. Sato, K. Ueda, H. Chihara, T. Watanabe, K. Nakano, H. Saito, and N. Maehara. 1995. Possible receptor for exfoliative toxins produced by Staphylococcus hyicus and Staphylococcus aureus. Infect. Immun. 63:1591-1594.
266. Telford, D. R., J. A. Morris, P. Hughes, A. R. Conway, S. Lee, A. J. Barson, and D. B. Drucker. 1989. The nasopharyngeal flora in sudden infant death syndrome. J. Infect 18:125-130.
267. Todd, J. K. 1985. Staphylococcal toxin syndromes. Annu. Rev. Med. 36: 1017-1019.
268. Tokura, Y., P. W. Heald, S. L. Yan, and R. L. Edelson. 1992. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins J. Investig. Dermatol 98:33-37.
269. Tokura, Y., J. Yagi, M. O'Malley, J. Lewis, M. Takigawa, R. Edelson, and R. E. Tigelaar. 1994. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of langerhan cells or class II-bearing keratinocytes to produce T-cell activating cytokines J Investig Dermatol. 102:31-38
270. Toyota, E., H. Mitake, Y. Mikame, I. Shichi, S. Morita, T. Morishita, M. Kasahara, and Y. Kobayashi. 1994. A case of TSS complicated with SSSS in an adult with liver cirrhosis. J Jpn Assoc. Infect. Dis. 68:1421-1427. (In Japanese.)
271. Vath, G. M., C. A. Earhart, J. V. Rago, M. H. Kim, G. A. Bohach, P. M. Schlievert, and D. H. Ohlendorf. 1997. The structure of the superantigen exfoliative toxin A suggests a novel regulation as a serine protease. Biochemistry 36:1559-1566.
272. Verba, V., and A. Tarkowski. 1996. Participation of V beta 4(+)-, V beta 7(+)-, and V beta 11(+)-T lymphocytes in haematogenously acquired Staphylococcus aureus nephritis. Scand. J. Immunol. 44:261-266
273. Verber, I. G., and F. S. Pagan. 1993. What cord care - if any? Arch. Dis. Child. 68:594-596.
274. Volc-Platzer, B., O. Majdix, K. Knapp, K. Wolff, W. Hinterberger, K. Lechner, and G. Stingl. 1984. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J. Exp Med. 159:1784-1789.
275. Voller, A., D. Bidwell, and A. Bartlett. 1980. Enzyme-linked immunosorbent assay, p. 359-371. In N. R. Rose and H Friedman (ed.), Manual of clinical immunology. American Society for Microbiology, Washington, D.C.
276. Von Rittershain, G. R. 1878. Die exfoliative dermatitis jungener senglinge. Z. Kinderheilkd. 2:3-23
277. Watkinson, M., and A. Dyas. 1992. Staphylococcus aureus still colonises the untreated neonatal umbilicus. J. Hosp. Infect. 21:131-136.
278. Wiley, B. B., S. Allman, M. Rogolsky, C. W. Norden, and L. A. Glasgow. 1974. Staphylococcal scalded skin syndrome, potentiation by immunosuppression in mice toxin-mediated exfoliation in a healthy adult. Infect. Immun. 9:636-640.
279. Wiley, B. B., and M. S. Rogolsky. 1985. Phospholipase activity associated with electrfocused Staphylococcal exfoliative toxin, p. 295-300. In J. Jeljaszewicz (ed.), The staphylococci. Gustav Fischer Verlag, Stuttgart, Germany.
280. Willard, D., H. Monteil, Y. Piemont, R. Assi, J. Messer, J. Lavillaureix, R. Minck, and R. Gander. 1982. L'exfoliatine dans les staphylococcies neonatales. Nouv. Presse Med. 11:3769-3771.
281. Winkler, F. K., A. D'Arcy, and W. Hunziker. 1990. Structure of human pancreatic lipase. Nature 343:771-774.
282. Winternitz, R. 1898. Ein Beitrag zur Kenntnis der Dermatitis exfoliativa neonatorum (Ritter) Arch Dermatol. Syphilis 44:397-416.
283. Wolinsky, E., P. J. Lipsitz, E. A. Mortimer, and C. H. Kammelkamp. Acquisition of staphylococci in newborns: direct versus indirect transmission. Lancet ii:620-622.
284. Woodworth, T. G., and J. C. Nichols. 1995. Recombinant fusion toxins - a new class of targeted biologic therapeutics. Cancer Treat. Res. 68:145-160.
285. Wong, G. W., S. J. Oppenheimer, R. M. Evans, S. S. Leung, and J. C. Cheng. 1993. Pyomyositis and Staphylococcal scalded skin syndrome. Acta Paediatr. 82:113-115.
286. Wuepper, K. D., R. L. Dimond, and D. D. Knutson. 1975. Studies of the mechanism of epidermal injury by a Staphylococcal epidermolytic toxin. J. Investig. Dermatol. 65:191-200.
287. Wuepper, K. D., D. H. Baker, and R. L. Dimond. 1976 Measurement of the Staphylococcal epidermolytic toxin: a comparison of bioassay, radial immunodiffusion, and radioimmunoassay. J Investig. Dermatol. 67:526-530.
288. Yokota, S., T. Imagawa, S. Kataakura, T. Mitsuda, and T. Arai. 1996. Staphylococcal scalded skin syndrome caused by exfoliative toxin B-producing methicillin-resistant Staphylococcus aureus Eur. J. Paediatr. 155:722.
289. Yokote, R., Y. Tokura, F. Furukawa, and M. Takigawa. 1995. Susceptible responsiveness to bacterial superantigens in peripheral blood mononuclear cells from patients with psoriasis. Arch. Dermatol. Res 287:443-447.
290. Yoo, C. S., B. C. Wang, and M. Sax. 1978. Preliminary crystallographic data for Staphylococcus aureus exfoliative toxin. J. Mol. Biol. 124:421-423.
291. Zhao, Y. X., A. Ljungdahl, T. Olsson, and A. Tarkowski. 1996. In situ hybridisation analysis synovial and systemic cytokine messenger RNA expression in superantigen-mediated staphylococcal arthritis. Arthritis Rheum. 39:959-967